Thomas Laur

Thomas Laur serves as CEO at DNAnexus. DNAnexus operates in the research sector with approximately 280.0 employees. The company is headquartered in Boston, Massachusetts. DNAnexus generates annual revenue of 40000000.0. To date, DNAnexus has raised 456000000.0 in total funding, with the most recent round being Series H.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at DNAnexus.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Salesforce Route 53 Amazon SES Sendgrid Gmail Google Apps Microsoft Office 365 Mixpanel VueJS CloudFlare Media Temple SSL Drift React Redux React Datadog NetSuite Salesforce Service Cloud Salesforce Live Agent MongoDB Hubspot StatusPage IO Facebook Login (Connect) YouTube ShareThis DoubleClick Mobile Friendly Open AdStream (Appnexus) Google Tag Manager Google Font API iTunes Hotjar Facebook Widget Linkedin Widget Google Play Linkedin Login Linkedin Marketing Solutions Google Analytics SmartRecruiters Bootstrap Framework DoubleClick Conversion Google Dynamic Remarketing Remote AI

data management computational biology bioinformatics cloud computing clinicalgrade security electronic health records multimodal data population health precision health application platforms data visualization enterprise software information technology software biotechnology research bioinformatics tools data analysis multiomics collaboration platform compliance data security ngs data analysis translational informatics clinical diagnostics real-world evidence data sharing pipeline automation ai algorithms ml deployment cohort analysis data integration genomics proteomics pharmaceutical solutions biotech solutions academic research data silos data storage research collaboration professional services managed services regulatory compliance data quality metadata management secure data access custom solutions data forecasting clinical research biobanks health data analytics data governance data enrichment data ingestion custom applications research insights biomedical data analysis predictive analytics research environments project management metrics analysis genomic data management cloud platform ai & machine learning workflow automation security & compliance collaborative research biopharma academic medical centers real-world data scalable solutions enterprise-grade features genetic testing operational efficiency scientific discovery personalized treatments healthcare insights customer-centric approach return on investment cloud infrastructure research lifecycle genomic analysis partnerships industry leadership community collaboration information technology & services biotechnology enterprises computer software b2b health care information technology health care health wellness & fitness hospital & health care data analytics computer & network security professional training & coaching productivity internet infrastructure internet

OS

Omar Serang Chief Cloud Officer at DNAnexus

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

How can I contact Thomas Laur?

Thomas Laur's verified email address is available on MessageCEO. They currently work at DNAnexus. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Thomas Laur lead?

Thomas Laur is CEO at DNAnexus, a company in the research sector with 280.0 employees. The company is based in Boston, Massachusetts.

What industry is Thomas Laur in?

Thomas Laur works in the research industry as CEO at DNAnexus. MessageCEO provides verified contact information for executives across all major industries.

Is Thomas Laur's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Thomas Laur's profile is kept up-to-date with the latest available information.

Last updated: April 7, 2026